The US Food and Drug Administration has been asked to review MDMA, or midomafetamine, the active ingredient in street drugs like ecstasy and molly, along with therapy as a treatment for post-traumati… [read more]
FDA may review MDMA for the treatment of PTSD – CNN
You Might Also Like
The consumer is showing signs of rolling over soon says New York Life Investments’ Lauren Goodwin – CNBC Television
Breaking into China’s job market amid record-high youth unemployment – NBC News
